ArticleNanomaterials (Basel, Switzerland)2025
Individual ZnO-Ag Hybrid Nanorods for Synergistic Fluorescence Enhancement Towards Highly Sensitive and Miniaturized Biodetection.
Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Hybrid nanostructures can be engineered to exhibit superior functionality beyond the level attainable from each of the constituent nanomaterials by synergistically integrating their unique properties. In this work, we designed individual hybrid nanorods (NRs) of ZnO-Ag in different heterojunction configurations where each hybrid NR consists of a single ZnO NR forming a junction with a single Ag NR. We subsequently employed the ZnO-Ag hybrid NRs in the fluorescence detection of the model chemical and biological analytes, rhodamine 6G (R6G), and tumor necrosis factor-α (TNF-α), that undergo simple as well as more complex immunoreaction steps on the hybrid NRs. We determine how parameters such as the analyte concentration, ZnO-Ag heterojunction configuration, and NR length can influence the fluorescence signals, enhancement factors (EFs), as well as changes in EFs (%EFs) at different positions on the hybrid NRs. We provide much needed insights into the fluorescence enhancement capability of single hybrid NR systems using a signal source located external to the NRs. Moreover, we identify key consideration factors that are critical to the design and optimization of a hybrid NR platform for achieving high signal enhancements. We show that higher EFs are consistently observed from the junction relative to other positions in a given hybrid NR, from the end-end relative to other heterojunction configurations, and from longer than shorter ZnO NRs. Our research efforts demonstrate that the synergistic interplay of the two component NRs of ZnO and Ag escalates the fluorescence detection capability of the ZnO-Ag hybrid NR. A superior enhancement level surpassing those attainable by each component NR alone can be obtained from the hybrid NR. Hence, our work further substantiates the potential utility of individual semiconductor-metal hybrid NRs for highly miniaturized and ultra-trace level detection, especially by leveraging the critical consideration factors to achieve a higher detection capability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.